EWC Code
Medicines other than cytotoxic
EUR-Lex Commission Decision 2000/532/EC — Official Journal L 226, 06/09/2000Have a 20 01 32 stream? See the dossier that replaces the feasibility study.
See the validation dossier850,000 tonnes/year EU clinical waste · €1.8B clinical waste management market
Primary buyers include Hazardous waste treatment.
Get your full stream analysisAnnual Volume (EU)
850,000 tonnes/year EU clinical waste
Valorisation Range
€1.8B clinical waste management market
Primary Route
High-temperature incineration
Need verified buyer contacts with location-specific pricing?
Get contacts for EWC 20 01 32EWC 20 01 32 is a specific sub-code under EWC 18 01 — Wastes from natal care, diagnosis, treatment or prevention of disease in humans. The classification guidance below applies to this waste stream.
EWC 18 01 covers wastes arising from natal care, diagnosis, treatment and prevention of disease in humans. Sub-entries distinguish by infection risk and hazard: 18 01 01 (sharps not infectious), 18 01 02 (body parts and organs including blood bags), 18 01 03* (infectious waste — sharps, dressings, linen from infectious patients), 18 01 04 (non-infectious wastes — dressings, plaster casts from non-infectious sources), 18 01 06* (chemicals containing dangerous substances), 18 01 07 (non-hazardous chemicals), 18 01 08* (cytotoxic and cytostatic medicines), 18 01 09 (non-hazardous medicines) and 18 01 10* (amalgam waste from dental care).
Clinical waste (18 01 03*) classification requires risk assessment at point of generation. Waste from patients with known or suspected infectious conditions (Category A pathogens: Ebola, Lassa, MRSA, CJD) classified as Category A infectious substance. Standard clinical waste from non-infectious patients may be lower risk but still requires controlled disposal to prevent healthcare-associated infection.
Cytotoxic and cytostatic medicines (18 01 08*) — primarily cancer chemotherapy drugs — are acutely toxic, mutagenic and carcinogenic. Dedicated waste streams in sealed yellow UN containers, never mixed with general clinical waste. Amalgam from dental practices (18 01 10*) contains mercury; amalgam separators mandatory in EU dental practices under Mercury Regulation 2017/852.
Typical Generators
Established valorisation pathways for EWC 20 01 32, ranked by economic value and market depth.
Infectious clinical waste (18 01 03*) and cytotoxic waste (18 01 08*) incinerated at permitted medical waste incinerator at ≥850°C (≥1100°C for cytotoxics) with ≥2 second dwell time per IED Chapter IV. Incineration is definitive destruction; ash disposed as hazardous waste.
Non-cytotoxic infectious clinical waste may be treated by validated alternative technologies: autoclaving (134°C, 18 min), microwave or chemical disinfection. Treated waste may then be disposed as municipal solid waste. Validation against specific pathogens required under national approval.
Dental amalgam waste (18 01 10*) collected by amalgam separator, amalgam capsule waste and extracted teeth with amalgam fillings sent to licensed mercury recovery facility. Mercury recovered for reuse under Mercury Regulation exemptions for dental amalgam.
These are the established routes for EWC 20 01 32. Which one your stream qualifies for depends on its composition, volume and region.
See how this gets validatedPrimary & secondary off-takers
Licensed clinical waste incinerators and treatment facilities
Hospitals generating clinical waste streams requiring managed disposal
Mercury recovery from dental amalgam waste under Mercury Regulation
Pharmaceutical returns — expired and unused medicines from 18 01 09
Common materials that take EWC 20 01 32 depending on where the waste arises.
Sectors that valorise EWC 20 01 32 as an input material or secondary raw material.
Your medicines other than cytotoxic stream is assessed against chemistry, waste classification and proven recovery routes — graded results in your browser in seconds. No call, no commitment.
Recovery tiers only. For numbers that survive a technical review, see the validation dossier.